Single nucleotide polymorphisms of the FTO gene and cancer risk: an overview

Molecular Biology Reports

Volumn 42, Issue 3, 2015, Pages 699-704

  Hernández Caballero, Marta Elena ^a   Sierra Ramírez, José Alfredo ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Cancer risk factors; FTO; Obesity; SNP

Indexed keywords

CELL PROTEIN; FTO PROTEIN; GROWTH FACTOR; MELANOCORTIN 4 RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; FTO PROTEIN, HUMAN; PROTEIN;

ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; COLON CANCER; CUTL1 GENE; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FTO GENE; GALLBLADDER CANCER; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GROWTH RETARDATION; HEMATOLOGIC MALIGNANCY; HETEROZYGOSITY; HIGH RISK PATIENT; HOMOZYGOSITY; HUMAN; HYPERINSULINEMIA; HYPERPHAGIA; INFLAMMATION; INSULIN RESISTANCE; INTRON; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NUTRITIONAL STATUS; OBESITY; OVARY CANCER; OXIDATIVE STRESS; PANCREAS CANCER; POSTMENOPAUSE; PREVALENCE; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; RBL2 GENE; RECTUM CANCER; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CANCER; ALLELE; ANIMAL; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; NEOPLASMS; RISK;

ALLELES; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK;

EID: 84925463290     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3817-y     Document Type: Article

References (44)

1. Sur I, Tuupanen S, Whitington T et al (2013) Lessons from functional analysis of genome-wide association studies. Cancer Res 73:4180–4184
2. Finucane MM, Stevens GA, Cowan MJ et al (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological with 960 country-years and 9.1 million participants. Global burden of metabolic risk factors of chronic diseases collaborating group (Body Mass Index). Lancet 337:557–567
3. Haidar YM, Cosman BC (2011) Obesity epidemiology. Clin Colon Rectal Surg 24:205–210
4. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591
5. Ligibel JA, Strickler HD (2013) Obesity and its impact on breast cancer. Am Soc Clin Oncol Educ Book 2013:52–59
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospective studied cohort of U.S. adults. N Engl J Med 348:1625–1638
7. Sarfstein R, Friedman Y, Attias-Geva Z et al (2013) Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners. PLoS One 8:e61537
8. Huang Z, Hankinson SE, Colditz GA et al (1997) Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407–1411
9. Trentham-Dietz A, Newcomb PA, Storer BE et al (1997) Body size and risk of breast cancer. Am J Epidemiol 145:1011–1019
10. Anderson GL, Chlebowski RT, Aragaki AK et al (2012) Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomised placebo-controlled trial. Lancet Oncol 13:476–486
11. Scuteri A, Sanna S, Chen WM et al (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3:e115
12. Herrera BM, Lindgren CM (2010) The genetics of obesity. Curr Diab Rep 10:498–505
13. Frayling TM, Timpson NJ, Weedon NM et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894
14. Speliotes EK, Willer CJ, Berndt SI et al (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937–948
15. Stratigopoulos G, Padilla SL, LeDuc CA et al (2008) Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol 294:R1185–R1196
16. Boissel S, Reish O, Proulx K et al (2009) Loss-of-function mutation in the dioxygenaseencoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet 85:106–111
17. Meyre D, Proulx K, Kawagoe-Takaki H et al (2010) Prevalence of loss of function FTO mutations in lean and obese individuals. Diabetes 59:311–318
18. Chorley BN, Wang X, Campbell MR et al (2008) Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: current and developing technologies. Mutat Res 659:147–157
19. Jowett JB, Curran JE, Johnson MP, Carless MA, Göring HH, Dyer TD et al (2010) Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes 59(3):726–732
20. Berulava T, Horsthemke B (2010) Comment on: Jowett et al. (2010) Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes; 59:726–732. Diabetes 59:e9
21. Berulava T, Horsthemke B (2010) The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet 18:1054–1056
22. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gómez-Marín C et al (2014) Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507:371–375
23. Brennan P, McKay J, Moore L et al (2009) Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol 38:971–975
24. Lewis SJ, Murad A, Chen L et al (2010) Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One 5:e13485
25. Nock NL, Plummer SJ, Thompson CL et al (2011) FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis 32:748–756
26. Hubacek JA, Dlouha D (2012) The risk of sporadic colorectal cancer development is not influenced by fat mass and obesity related gene polymorphism in Slavs. Eur J Intern Med 23:e175–e176
27. Tarabra E, Actis GC, Fadda M et al (2012) The obesity gene and colorectal cancer risk: a population study in Northern Italy. Eur J Intern Med 23:65–69
28. Lim U, Wilkens LR, Monroe KR et al (2012) Susceptibility variants for obesity and colorectal cancer risk: the multiethnic cohort and PAGE studies. Int J Cancer 131:E1038–E1043
29. Tang H, Dong X, Hassan M et al (2011) Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 20:779–792
30. Pierce BL, Austin MA, Ahsan H (2011) Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control 22:877–883
31. Li G, Chen Q, Wang L, Ke D, Yuan Z (2012) Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls. Tumour Biol 33:1237–1243
32. Lin Y, Ueda J, Yagyu K, Ishii H, Ueno M, Egawa N et al (2013) Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan. BMC Cancer 8(13):337
33. Kitahara CM, Neta G, Pfeiffer RM et al (2012) Common obesity-related genetic variants and papillary thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 21:2268–2271
34. Delahanty RJ, Beeghly-Fadiel A, Xiang YB et al (2011) Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai endometrial cancer genetics study. Am J Epidemiol 174:1115–1126
35. Lurie G, Gaudet MM, Spurdle AB et al (2011) The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One 6:e16756
36. Gaudet MM, Yang HP, Bosquet JG et al (2010) No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 19:2106–2109
37. Brinton L, Swanson C (1992) Height and weight at various ages and risk of breast cancer. Ann Epidemiol 2:597–609
38. Long J, Zhang B, Signorello LB et al (2013) Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. PLoS One 8:e58350
39. Kaklamani V, Yi N, Sadim M et al (2011) The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet 12:52
40. Kusinska R, Górniak P, Pastorczak A et al (2012) Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep 39:2915–2919
41. Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjær L, John EM et al (2012) Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population. Cancer Epidemiol Biomarkers Prev 21:2261–2267
42. Garcia-Closas M, Couch FJ, Lindstrom S et al (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45:392–8, 398e1-2
43. da Cunha PA, de Carlos Back LK, Sereia AF et al (2013) Interaction between obesity-related genes, FTO and MC4R, associated to an increase of breast cancer risk. Mol Biol Rep 40:6657–6664
44. Iles MM, Law MH, Stacey SN et al (2013) A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet 45:428–432